GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » EBIT

Merit Medical Systems (Merit Medical Systems) EBIT : $142 Mil (TTM As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Merit Medical Systems EBIT?

Merit Medical Systems's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $42 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $142 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Merit Medical Systems's annualized ROC % for the quarter that ended in Mar. 2024 was 7.55%. Merit Medical Systems's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 21.71%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Merit Medical Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.84%.


Merit Medical Systems EBIT Historical Data

The historical data trend for Merit Medical Systems's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems EBIT Chart

Merit Medical Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.90 -3.24 59.18 88.97 127.60

Merit Medical Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.51 28.58 35.06 36.44 42.39

Competitive Comparison of Merit Medical Systems's EBIT

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's EV-to-EBIT falls into.



Merit Medical Systems EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merit Medical Systems  (NAS:MMSI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Merit Medical Systems's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=143.22 * ( 1 - 17.78% )/( (1547.016 + 1573.559)/ 2 )
=117.755484/1560.2875
=7.55 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2325.244 - 191.192 - ( 587.036 - max(0, 203.564 - 1108.47+587.036))
=1547.016

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2326.352 - 170.872 - ( 581.921 - max(0, 183.344 - 1105.275+581.921))
=1573.559

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Merit Medical Systems's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=169.576/( ( (446.57 + max(318.581, 0)) + (456.3 + max(341.049, 0)) )/ 2 )
=169.576/( ( 765.151 + 797.349 )/ 2 )
=169.576/781.25
=21.71 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(177.885 + 303.871 + 28.302) - (191.192 + 0.285 + 0)
=318.581

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(180.663 + 302.733 + 28.525) - (170.872 + 0 + -2.8421709430404E-14)
=341.049

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Merit Medical Systems's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=142.483/5009.007
=2.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merit Medical Systems EBIT Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Merit Medical Systems (Merit Medical Systems) Business Description

Traded in Other Exchanges
Address
1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. Majority of the revenue is earned from Cardiovascular segment. United States generates majority of the revenue.
Executives
F. Ann Millner director 4275 SPRING ROAD, OGDEN UT 84403
Neil Peterson officer: Chief Operating Officer 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
A Scott Anderson director ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Michel James Voigt officer: Chief Human Resources Officer 1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
Fred P Lampropoulos director, officer: President & CEO
Lynne Ward director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra officer: Interim CFO 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Joseph Wright officer: President, International 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Brian G. Lloyd officer: Chief Legal Officer, Secretary 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost officer: Chief Operating Officer 1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks officer: Chief Strategy & Innovation O. 1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132
Michael R Mcdonnell director C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Jill Anderson director 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans director C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102

Merit Medical Systems (Merit Medical Systems) Headlines